Investor Relations

Stock Quote (NASDAQ: PODD)

- 1.18
Day High:
Day Low:
4:00 PM ET on Feb 27, 2015
Delayed ~20 min. By eSignal.
Stock price graph

Corporate Profile

Insulet Corporation is an innovative medical device company based in Billerica, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through its revolutionary OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy.

Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. Despite these benefits, most people still choose MDI therapy largely due to the complexity, cost and inconvenience of conventional..More ▼

View all »   RSSRecent Releases

Feb 28, 2015
Insulet Corporation to Present at Upcoming Investor Conferences

Feb 26, 2015
Insulet Reports Fourth Quarter and Full Year 2014 Financial Results

View all »Events & Presentations

Feb 26, 2015
Q4 2014 Insulet Corporation Earnings Conf Call
Webcast Listen to webcast
PDF Historical Revenue by Business Line  178.0 KB   Add to Briefcase

Feb 11, 2015
Insulet Corporation to Present at the 2015 Leerink Global Healthcare Conference
Webcast Listen to webcast